Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.
September 25, 2023
3 chosen as UAB VIPs for third-quarter 2023
Emily Bruer, Amanda Dove and Dina Jones are the third-quarter 2023 honorees of the UAB Shared Values in Action Program, which honors those whose work exemplifies and embodies Forging the Future’s shared values. Nominations for fourth-quarter 2023 honorees are open through Nov. 8.
Published in
Awards & Honors
September 21, 2023
Do you sometimes feel hopeless, or that life has no purpose?
UAB researchers are looking for adults (ages 25-65) who are suffering from demoralization - feelings of hopelessness or meaninglessness - to participate in a research study evaluating a novel medication.
To see if you qualify call 205-379-7527.
To see if you qualify call 205-379-7527.
Published in
Clinical Trials
September 25, 2023
UAB to share draft of new strategic plan soon
The new draft strategic plan will be shared Oct. 25 to solicit feedback from the campus community before it is finalized and presented to the UA System Board of Trustees.
Published in
Campus News
With fall semester already in high gear, here is a quick refresher on all that the UAB Career Center offers to support students on their career journeys.
Published in
Teaching & Learning
September 05, 2023
Expert advice for a new phase of COVID
UAB experts encourage healthy behaviors, responsible symptom management and vaccines to avoid and manage respiratory illnesses like COVID, common cold, RSV or the flu.
Published in
Campus Safety
September 01, 2023
How did we do? Forging the Future of Patient Care
Published in
Campus News
September 01, 2023
How did we do? Forging the Future of Community Engagement
Revisiting the successes in community engagement achieved together through UAB’s current strategic plan.
Published in
Campus News
September 01, 2023
How did we do? Forging the Future of Research
Published in
Campus News
September 01, 2023
How did we do? Forging the Future of Education
Published in
Campus News
CURB-2 is an abbreviation we use to refer to this study because there was a similar study completed and published in 2016 called CURB, which stands for Cocaine Use Reduction with Buprenorphine. The results from that study showed that using injectable naltrexone and sublingual buprenorphine was beneficial to participants on high doses of the medication. This study will give injectable naltrexone and injectable buprenorphine to make sure medication doses are consistent to confirm potential benefits.
There are no approved treatments specifically for cocaine use disorder. We are looking for adults (18-65 years of age) who are using cocaine and who are interested in reducing or stopping their use. The purpose of our study is to test a combination of two medications for 2 months as a possible treatment for cocaine use disorder.
This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine. Study medication and assessments will be provided to participants at no cost. Participants will receive compensation for their time and efforts.
Study information will be kept strictly confidential. Your privacy is important to us.
Call us for more information at 205-996-0211 or email us at curb2study@uabmc.edu
There are no approved treatments specifically for cocaine use disorder. We are looking for adults (18-65 years of age) who are using cocaine and who are interested in reducing or stopping their use. The purpose of our study is to test a combination of two medications for 2 months as a possible treatment for cocaine use disorder.
This study includes the use of a placebo, which looks like the medication we are testing but does not include any active medicine. Study medication and assessments will be provided to participants at no cost. Participants will receive compensation for their time and efforts.
Study information will be kept strictly confidential. Your privacy is important to us.
Call us for more information at 205-996-0211 or email us at curb2study@uabmc.edu
Published in
Clinical Trials